- Posts by Kelsey J. McElveen
OfficerAs a member of the firm’s Intellectual Property Litigation group, Kelsey focuses her practice on patent litigation under the Hatch-Waxman Act. After nearly a decade of experience working on Abbreviated New Drug Application ...
The U.S. Supreme Court recently issued its decision in Amgen Inc. v. Sanofi; a decision long-awaited by patent practitioners. In its decision, the Court unanimously held that several of Amgen’s patent claims to a class of antibodies were invalid for lack of enablement.
- EventImplications of a Second Trump Administration on Trade and Investment Between the U.S. and Asia
- Legal UpdateFTC Proposed Order Requires Website Accessibility Vendor accessiBe To Pay $1 Million for ‘Deceptive Claims that its AI Product Could Make Websites Compliant with Accessibility Guidelines’
- Legal UpdateForeign Students Warned to Arrive on Campus Before Trump Administration Begins
- Legal UpdateDHS Announces Permanent Increase of Automatic Extension Period for Certain Work Authorization Renewal Applicants